Sage Therapeutics, Shionogi partner on development of SAGE-217 in Asia
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics provides update on zuranolone development program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why Sage Therapeutics Is Booming
Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S.........»»
Sage Therapeutics price target lowered to $77 from $81 at Mizuho
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics reports Q1 EPS ($1.64), consensus ($1.91)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics management to meet virtually with Oppenheimer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics assumed with an Overweight at Piper Sandler
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hoth Therapeutics" Partner Voltron Therapeutics Reports Encouraging Preclinical Data From COVID-19 Vaccine Candidate
Hoth Therapeutics Inc's (NASDAQ: HOTH) development partner, Voltron Therapeutics Inc has announced read more.....»»
Sage Therapeutics" zuranolone for depression shows positive Phase 3 results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics announces departure of COO Mike Cloonan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics management to meet virtually with Wedbush
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics downgraded to Neutral from Buy at Mizuho
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics price target raised to $102 from $90 at Oppenheimer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics reports Q4 EPS $18.19, consensus (35c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics resumed with a Market Perform at Raymond James
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics downgraded to market perform at BMO Capital
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Sage Therapeutics cut to Market Perform at BMO Capital on valuation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics downgraded to Market Perform from Outperform at BMO Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics price target raised to $98 from $83 at Wedbush
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sage Therapeutics downgraded to Sector Perform at RBC Capital on valuation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»